^
Association details:
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
Title:

First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia

Published date:
07/25/2020
Excerpt:
Our patient, having progressed through standard of care treatments, was trialled on novel treatments including dasatinib, venetoclax and vemurafenib.
DOI:
10.1111/bjh.16992